ELDN: Presents Kidney Transplant Data
Eledon Pharma presents new long-term data from Phase 2 BESTOW clinical program evaluating Tegoprubart in patients undergoing kidney transplantation at ATC 2026
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.